Vivid E80 vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Vivid E80

by GE HealthCare

EchoNext

by Pathway Labs

AI Verdict

These tools are adjacent in their focus on cardiovascular health but serve different primary functions. Vivid E80 is an AI-powered ultrasound system that provides advanced imaging and diagnostic precision for cardiology, while EchoNext is an AI tool that analyzes standard ECGs to detect hidden structural heart disease, acting as a screening tool to identify patients who should proceed to an echocardiogram.

Choose Vivid E80 if…

Choose the Vivid E80 if your cardiology department requires an advanced, AI-powered ultrasound system for comprehensive cardiovascular imaging and analysis. It excels in real-time 2D, 3D, and 4D imaging, offering features like AI Auto Measure 2D and Easy AutoEF to enhance diagnostic precision and workflow efficiency for a wide range of cardiac and other specialized ultrasound examinations.

View Vivid E80 →

Choose EchoNext if…

Choose EchoNext if you need an FDA-cleared AI tool to screen a broad patient population for hidden structural heart disease using standard ECGs. This tool is ideal for early detection of conditions like heart failure, valve disease, and pulmonary hypertension, especially in settings where a non-invasive, cost-effective initial screening is desired before more advanced imaging like echocardiography is performed.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Vivid E80	EchoNext
Pricing	Quote-based	Starts at $600/month
Deployment	On-premise (medical device)	Available through the OpenEvidence clinical decision support platform.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Yes AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Vivid E80

Vivid E80 is an ultrasound system with integrated AI features designed to enhance diagnostic precision and workflow efficiency. Its ergonomic design and AI-based measurement tools aim to improve the user experience and reduce exam times. EchoNext, while integrated into a clinical decision support platform, is primarily an analytical tool, and its direct user interface for clinicians is less emphasized in the available information.

Clinical Value

EchoNext

EchoNext demonstrates high clinical value by detecting hidden structural heart disease from standard ECGs, outperforming cardiologists in studies. This offers a scalable and affordable front-line screening tool, potentially leading to earlier diagnosis and improved outcomes, especially in underserved areas. Vivid E80 enhances existing ultrasound diagnostics with AI, but EchoNext offers a novel screening paradigm for conditions often missed.

Pricing & Value

EchoNext

EchoNext offers tiered pricing starting at $600/month, with transparent details including implementation fees and annual discounts, making its cost structure clear. Vivid E80 uses a quote-based pricing model, which lacks transparency and makes it difficult to assess its overall value proposition without direct engagement with GE HealthCare.

Enterprise Readiness

EchoNext

EchoNext is available through the OpenEvidence clinical decision support platform, which is used by 650,000 U.S. physicians, indicating strong integration capabilities and broad accessibility for healthcare systems. Vivid E80 is an on-premise medical device, which, while robust, may present more complex deployment and integration challenges for large enterprises compared to a platform-based AI tool.

Innovation

EchoNext

EchoNext represents a significant innovation by using AI to detect hidden structural heart disease from routine ECGs, a capability that previously required more expensive and less accessible imaging. This creates a new screening paradigm for heart disease. Vivid E80, while incorporating advanced AI into ultrasound, primarily enhances existing diagnostic workflows rather than introducing a fundamentally new screening method.

Support & Docs

Tie

Both tools are FDA-cleared and come from reputable companies, implying a commitment to support and documentation. However, specific details on the breadth and accessibility of support resources or documentation beyond basic compliance are not extensively detailed for either product in the provided information or web searches. Therefore, a definitive winner cannot be determined.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Vivid E80	EchoNext
Name	Vivid E80	EchoNext
Company	GE HealthCare	Pathway Labs
Description	GE HealthCare's Vivid E80, E90, and E95 are advanced AI-powered ultrasound systems for cardiovascular imaging, not physician directory tools. They enhance diagnostic precision and workflow efficiency through integrated AI features.	EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI, Clinical Decision Support & Reference, Lab & Diagnostics
Key Features	AI Auto Measure 2D (for left ventricle dimensions), Easy AutoEF (AI-based ejection fraction measurement), Easy AFI LV (AI-based global and segmental strain measurements), AI Cardiac Auto Doppler, AI FlexiViews LAA (Left Atrial Appendage localization), Auto Tissue (real-time image processing for automatic gain optimization), Spectrum Recognition (semi-automatic Doppler spectrum measurement), DICOMu00ae connectivity for image processing and reporting	AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support

Videos

Demos, reviews, and walkthroughs featuring Vivid E80 and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools fit into existing clinical workflows for cardiac assessment?

Vivid E80 is an ultrasound system that integrates AI features directly into the imaging workflow to automate measurements and enhance diagnostic precision during echocardiograms, potentially reducing exam times by 7-10 minutes. EchoNext, on the other hand, analyzes standard ECGs to screen for hidden structural heart disease and integrates with the OpenEvidence clinical decision support platform, allowing its screening output to be available within a tool many physicians already use.

What is the depth of EHR integration for each tool, and how does it support data flow?

The Vivid E80 systems offer DICOM connectivity for image processing and reporting, and DICOM SR Measurement Transfer for seamless integration with GE HealthCare and other industry reporting systems and EMRs. EchoNext integrates through the OpenEvidence clinical decision support platform, which aims to embed its screening output directly into existing physician workflows, rather than requiring a separate system.

What are the reported accuracy and sensitivity of each tool in detecting cardiac conditions?

The Vivid E80's AI Auto Measure 2D feature performs comparably to human users with 100% reproducibility, and AI Auto Measure Spectrum Recognition has 98% accuracy and 100% reproducibility. EchoNext has demonstrated higher accuracy than cardiologists in detecting structural heart problems from ECGs, identifying 77% of structural heart problems compared to cardiologists' 64% accuracy in a study of 3,200 ECGs.

Which cardiac specialties are these tools best suited for, and what specific clinical problems do they address?

Vivid E80 is an advanced ultrasound system primarily for cardiology and radiology, enhancing diagnostic precision and workflow efficiency in cardiovascular imaging through AI features like auto-measurements for left ventricle dimensions, ejection fraction, and strain. EchoNext is an AI tool for cardiology, family medicine, hospital medicine, and internal medicine, designed to analyze standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, often before symptoms appear.

What is the typical learning curve for physicians to effectively use these AI features, and what kind of support is available?

For Vivid E80, AI-powered applications automate common clinical measurements, aiming to reduce manual workflow and clicks, suggesting a focus on ease of use and efficiency. EchoNext is designed to integrate into existing clinical decision support platforms, which could imply a lower learning curve as it leverages familiar interfaces. Both companies would typically offer support, but specific details on learning curve and support quality beyond general statements are not provided in the given information.

What audit-trail features are available to track the AI's contribution to diagnoses and clinical decisions?

The provided information does not explicitly detail specific audit-trail features for either the Vivid E80 or EchoNext regarding the AI's contribution to diagnoses and clinical decisions. However, medical devices and clinical decision support tools typically incorporate logging and tracking functionalities to ensure accountability and transparency in their operation.

Are there customer references or published case studies available that demonstrate the real-world impact of these tools in a multi-site rollout?

For EchoNext, a case published in Nature Medicine highlighted its role in detecting undiagnosed heart failure that led to a heart transplant, described as the first peer-reviewed account of its kind. EchoNext has also been validated in studies across more than 20 hospitals and 500,000 patients in the U.S. and Canada. While Vivid E80 has testimonials regarding reduced exam times, specific multi-site rollout case studies or customer references are not detailed in the provided information.